Quadrant Capital »

Entrada Therapeutics shares owned by Quadrant Capital

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Quadrant Capital from 13F filings

Historical chart of Quadrant Capital investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Quadrant Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Quadrant Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $228 18 12.67

More positions owned by Quadrant Capital

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
NVIDIA Corporation (NVDA)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Ishares Tr Core Msci Eafe (IEFA)
Schwab Strategic Tr Fundamental Us L (FNDX)
Amazon (AMZN)
Ishares Tr Core S&p Mcp Etf (IJH)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Procter & Gamble Company (PG)

View all positions for Quadrant Capital

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
5AM Venture Management
BlackRock
TCG Crossover Management
Vanguard Group
Vanguard Capital Management
Wellington Management Company
StepStone
Geode Capital Management
Millennium Management
State Street Corporation
Jones Hill Capital
Jacobs Levy Equity Management
Acadian Asset Management
Dimensional Fund Advisors

View all funds holding Entrada Therapeutics